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cells have unique tenogenic properties
Michael J Mienaltowski1,2,3*, Sheila M Adams1 and David E Birk1,2Abstract
Introduction: Multipotent progenitor populations exist within the tendon proper and peritenon of the Achilles
tendon. Progenitor populations derived from the tendon proper and peritenon are enriched with distinct cell types
that are distinguished by expression of markers of tendon and vascular or pericyte origins, respectively. The
objective of this study was to discern the unique tenogenic properties of tendon proper- and peritenon-derived
progenitors within an in vitro model. We hypothesized that progenitors from each region contribute differently to
tendon formation; thus, when incorporated into a regenerative model, progenitors from each region will respond
uniquely. Moreover, we hypothesized that cell populations like progenitors were capable of stimulating tenogenic
differentiation, so we generated conditioned media from these cell types to analyze their stimulatory potentials.
Methods: Isolated progenitors were seeded within fibrinogen/thrombin gel-based constructs with or without
supplementation with recombinant growth/differentiation factor-5 (GDF5). Early and late in culture, gene expression
of differentiation markers and matrix assembly genes was analyzed. Tendon construct ultrastructure was also
compared after 45 days. Moreover, conditioned media from tendon proper-derived progenitors, peritenon-derived
progenitors, or tenocytes was applied to each of the three cell types to determine paracrine stimulatory effects of
the factors secreted from each of the respective cell types.
Results: The cell orientation, extracellular domain and fibril organization of constructs were comparable to embryonic
tendon. The tendon proper-derived progenitors produced a more tendon-like construct than the peritenon-derived
progenitors. Seeded tendon proper-derived progenitors expressed greater levels of tenogenic markers and matrix
assembly genes, relative to peritenon-derived progenitors. However, GDF5 supplementation improved expression of
matrix assembly genes in peritenon progenitors and structurally led to increased mean fibril diameters. It also was found
that peritenon-derived progenitors secrete factor(s) stimulatory to tenocytes and tendon proper progenitors.
Conclusions: Data demonstrate that, relative to peritenon-derived progenitors, tendon proper progenitors have greater
potential for forming functional tendon-like tissue. Furthermore, factors secreted by peritenon-derived
progenitors suggest a trophic role for this cell type as well. Thus, these findings highlight the synergistic potential of
including these progenitor populations in restorative tendon engineering strategies.Introduction
Native repair of tendon following an injury such as a
rupture or a tear is achieved through intrinsic and ex-
trinsic mechanisms. When an injury occurs, leukocytes
and fibroblasts migrate into the lesion early in repair [1].* Correspondence: mjmienaltowski@ucdavis.edu
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article, unless otherwise stated.Recently, it was determined that many of these fibro-
blasts originate from the paratenon and are thus an ex-
trinsic source of cells involved in repair [2]. Moreover,
cells from within the endotenon are thought to serve as
an intrinsic source for repair, including tenocytes. Be-
sides terminally differentiated cells such as leukocytes
extrinsically and tenocytes intrinsically, multipotent pro-
genitor populations also have been demonstrated to exist
within the tendon proper and peritenon (paratenon and
epitenon) of the tendon [3,4]. Progenitor populations de-
rived from the tendon proper and peritenon of the
Achilles tendon are enriched with distinct cell types thatentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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vascular/pericyte origins, respectively [4]. Specifically, iso-
lated progenitors of the tendon proper express greater
levels of scleraxis and tenomodulin while progenitors of the
peritenon express greater levels of endomucin and promi-
nin 1 [4]. Preliminary studies indicate that progenitor cells
can be found within repair tissue of healing patellar tendon
injuries [5]. Thus, stem/progenitor cells also may contribute
to intrinsic and extrinsic tendon repair mechanisms.
Given the distinctions previously seen in the progeni-
tor cell populations, we hypothesized in this study that
tendon proper-derived stem/progenitors and peritenon-
derived stem/progenitors possess differing tenogenic
properties. Thus, we hypothesized that when incorpo-
rated into an in vitro regenerative model, progenitors
from each region will respond uniquely and produce
constructs with differing tenogenic properties. Teno-
genic properties include: collagen-rich protein compos-
ition, features of the hierarchical tendon structure, as
well as expression of known tenocyte markers [4,6-12].
To test these hypotheses, isolated peritenon- and tendon
proper-derived progenitors were seeded within a contract-
ing fibrinogen/thrombin gel-based tendon construct re-
generative tissue model [4,13-18]. Growth differentiation
factor 5 (GDF5) has been shown to influence tenocyte dif-
ferentiation and potentially tendon development, as well
as tendon homeostasis and tendon repair [9,19-24]. Thus,
additionally, we hypothesized that differences in tenogenic
properties will also be seen when each seeded progenitor
population is treated with GDF5. Finally, because intrinsic
and extrinsic mechanisms could work simultaneously
within injured tendon via cell-cell crosstalk among cell
types, conditioned media experiments were also performed
to further define interactions among the two enriched pro-
genitor cell populations and mature tenocytes, or more
specifically the outcomes of paracrine signaling.
Methods
Animals
Ninety-six thirty-day-old (P30) male ScxGFP mice were
used for twenty-four total progenitor and tenocyte isola-
tions. Tendons also were dissected from embryonic ScxGFP
mice (embryonic day (E)15 to E17) (n = 4) for controls in
ultrastructural comparisons and from postnatal day P1
ScxGFP mice (n = 2) for controls in immuno-histochemical
analyses of tendon constructs. ScxGFP mice contain the
transgenic tendon promoter Scx-driven reporter GFP [25].
The University of South Florida’s Institutional Animal
Care and Use Committee specifically approved this study’s
protocols (‘USF R3901’).
Progenitor cell isolation
Mice were euthanized and Achilles tendons with sur-
rounding paratenon tissues were dissected using a steriletechnique, and kept on ice in Dulbecco’s phosphate buffered
saline (D-PBS, Life Technologies, Benicia, CA, USA) with
antibiotics-antimycotics (100 U/ml penicillin, 100 μg/ml
streptomycin, 250 ng/ml amphotericin B, Life Technologies).
Each biological replicate represents eight Achilles tendons
from four mice. Progenitor cells were isolated from the
Achilles tendon proper as well as from the associated peri-
tenon (paratenon and epitenon), utilizing a series of enzyme
digestions as previously described [3,4,26]. Briefly, dissected
tendons were first treated with 0.5% type I collagenase
(CLS-1, Worthington, Lakewood, New Jersey, USA) and
0.25% trypsin (Life Technologies) in alpha minimum essen-
tial medium (alpha-MEM) for 10 minutes at 37°C. Then
the surfaces of the tendons were scraped carefully with a
rubber policeman to strip away the cells of the peritenon.
Peritenon cells were collected in ice-cold alpha-MEM. The
remaining tendon tissue was rinsed in Hank’s Balanced Salt
Solution, cut into 1-mm3 pieces, and transferred into a solu-
tion of 3 mg/ml CLS and 4 mg/ml Dispase II (Roche, Basel,
Switzerland). The digestion was undertaken at 90 oscilla-
tions per minute in a 37°C water bath for 20 minutes. Then
digested tendon proper was transferred to culture media
kept on ice, and fresh collagenase/dispase solution was
transferred into the tube with the remaining tendon pieces
for 10-minute incubations until all the tissue was digested,
each time adding the digest to the media (alpha-MEM,
2 mM L-glutamine, antibiotics/antimycotics, 100 μm 2-
mercaptoethanol, 20% fetal bovine serum (FBS)). From both
digests (peritenon and tendon), cells were strained with a
70 μm cell strainer. Cells were collected by centrifugation
for five minutes at 500 g, resuspended in media and counted
using a hemocytometer with Trypan blue staining. Tendon
and peritenon cells were plated in tissue culture flasks at 40
cells and 320 cells per cm2, respectively, so that adhering
cells form segregated colonies within the flasks. Fourteen
days into the culture, primary culture isolations of progeni-
tor cell colonies were collected and used for generating
tendon constructs or for the conditioned media experiment.Tenocyte isolation
Tenocytes were isolated from the tendon proper by re-
moving the paratenon with enzyme digestion as described
above. The remaining tendon tissue was rinsed in Hank’s
Balanced Salt Solution, cut into 1-mm3 pieces, and trans-
ferred into a type I collagenase/Dispase II solution, also as
described above. After digestion, cells were strained with a
70 μm cell strainer, collected by centrifugation for five mi-
nutes at 500 g, and resuspended in media. Tenocytes were
plated in tissue culture flasks (50,000 cells per T75), and
were grown in alpha-MEM with 2 mM L-glutamine,
antibiotics-antimycotics, 10% FBS. After fourteen days into
the culture, tenocytes also were used in the conditioned
media experiment.
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Tendon proper- and peritenon-derived progenitor cells
were seeded into a regenerative tendon construct model
as described previously [4,16]. Briefly, wells of six-well
plates were coated with SYLGARD polymer (Dow Chemical,
Midland, MI, USA). Within each well, two segments of
size 0 silk were each pinned with a pair of minutiens in-
sect pins (0.1 mm diameter, Fine Science Tools GmbH,
Heidelberg, Germany) in each of the two suture segments
positioned 10 mm apart. The contents of each well were
sterilized by treatment with 100% ethanol, exposure to
ultraviolet irradiation for 60 minutes and then rinsed in
PBS. Within each well, 6.15 × 105 tendon proper or perite-
non progenitor cells in 400 μl media, 83 μl of 20 mg/mL
fibrinogen, and 10 μl of 200 U/mL thrombin (Sigma, St
Louis, MO, USA) were combined and quickly spread over
the polymer surface between the two suture segments.
Plates were incubated at 37°C in alpha-MEM with 10%
FBS, 100 U/ml penicillin, 100 μg/mL streptomycin,
250 ng/ml amphotericin B, 2 mM L-glutamine and
200 μM ascorbic-2-phosphate, with or without GDF5
(100 ng/ml r-mGDF5, R&D Systems, Minneapolis, MN,
USA) [4,23,27]. Three times per week the plates were
scored to release the fibrin gel as it contracted as previ-
ously described [16], and the culture medium was chan-
ged. Over the first two weeks, gels contracted and tendon
constructs formed (Figure 1). Cultures were maintained
for up to 45 days.
Conditioned media experiment
After the initial expansion, stem/progenitor cells or teno-
cytes were trypsinized from flasks and seeded in mono-
layer culture in 12-well plates (5.0 × 104/well). Cells were
maintained in their respective phenotype maintenance
media: stem/progenitor (alpha-MEM, 2 mM L-glutamine,
antibiotics/antimycotics, 100 μm 2-mercaptoethanol, 20%
FBS) [3,4] or tenocytes (alpha-MEM, 2 mM L-glutamine,
antibiotics/antimycotics, 0.15 mM ascorbate-2-phosphate,
10% FBS) [28] for 24 hours. Then, cells were rinsed
with D-PBS and all cells received alpha-MEM, 1% FBS,Figure 1 Progenitor-seeded fibrin gels form tendon-like structures.
(A) Stem/progenitor cells are seeded within fibrinogen/thrombin; at Day
2, a distinct gel bridges the two silk sutures. (B) By Day 7, the fibrin
within the structure has commenced contracting. (C) By Day 14, the
construct has contracted into a long, narrow structure in which tension
is applied uniaxially. Representative images are from tendon
proper-derived stem/progenitor-cell-seeded constructs (Bar: 200 μm).L-glutamine, and antibiotics. After 18 hours, media were
collected and grouped as tenocyte-conditioned (Tn),
tendon-proper-stem/progenitor-conditioned (TP), and
peritenon-stem/progenitor-conditioned (PERI). Then each
cell type was treated with the conditioned media for
48 hours before cultures were terminated. Total RNA was
isolated from the cell layer in each well.
Electron microscopic examination of tenogenic
differentiation
After 45 days in culture, tendon constructs were processed
for transmission electron microscopy as described previ-
ously for tendons [4,29,30]. Biological replicates from each
sample group (n = 3 to 8) were sectioned using a Leica
Ultracut UCT ultramicrotome, and stained with 2% aque-
ous uranyl acetate and 1% phosphotungstic acid, pH 3.2.
Microscopy was undertaken using a JEOL 1400 Transmis-
sion Electron Microscope. Images were digitally captured
using a Gatan Orius widefield side mount CC Digital
camera. Eight cross-sectional images from non-overlapping
regions of the central portion of the construct taken at an
instrument magnification of 60,000x were used for measur-
ing diameters of fibrils formed within each biological repli-
cate. Digital images were randomized, masked and
transferred to a RM Biometrics-Bioquant Image Analysis
System (Memphis, TN, USA) for analysis. Five to eight
identical regions of interest (ROIs) per image were used on
each image. All fibrils within the predetermined ROIs were
measured until at least 100 fibrils were counted per image.
Gene expression profiling
After 7 and 45 days in culture, total RNA was extracted
from tendon proper- and peritenon-derived progenitor-
seeded constructs by mechanically homogenizing tissues
with a Tissue-Tearor (Biospec Products, Inc., Bartlesville,
OK, USA) in QIAzol reagent (Qiagen, Valencia, CA, USA)
and then using the QIAGEN RNeasy Plus Micro Kit [31].
Total RNA was isolated from cells in monolayer culture
(pre-seeded cells compared to constructs or monolayer cul-
tures for conditioned media studies) using the QIAGEN
RNeasy Plus Micro Kit. For quantitative real-time polymer-
ase chain reactions (RT-qPCR), total RNA (pre-seeded cells
and tendon constructs, 250 ng; conditioned media mono-
layer culture, 200 ng) for each sample was reverse tran-
scribed into cDNA using a High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, ABI, Foster City,
CA, USA). This cDNA was used as a template for RT-
qPCR with Fast-SYBR Green Master Mix (ABI). Assays were
performed using the StepONEPlus Real-Time PCR System
(ABI). Primers were designed using Primer Express software
(ABI) for the following genes: actin, beta (Actb); scleraxis
(Scx); tenomodulin (Tnmd); endomucin (Emcn); biglycan
(Bgn); decorin (Dcn); collagen, type I, alpha 1 (Col1a1); colla-
gen, type III, alpha 1 (Col3a1); collagen, type V, alpha 1
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type XII, alpha 1 (Col12a1); and collagen, type XIV, alpha
1 (Col14a1). Primer sequences can be found in Table 1.
Two technical replicates were performed for each biological
replicate (n = 5 to 8 per group for tendon constructs; n = 4 to
8 for the conditioned media experiment). The results were
adjusted for efficiency as measured by LinRegPCR using the
default fit option that measures the slope of a line containing
four to six data points and the highest R2 correlation value
[32,33]. RT-qPCR data were normalized relative to the
endogenous control gene, Actb.
Immuno-histochemical analysis of tendon constructs
Tendon construct protein content was analyzed alongside
of one day old (P1) ScxGFP mouse Achilles tendons using
an immuno-histochemical technique previously described
[34,35]. Briefly, dissected P1 Achilles tendons and 7-day
tendon constructs were fixed in 4% paraformaldehyde in
phosphate-buffered saline (PBS), pH 7.2, for two to four
hours at 4°C, then stored in an increasing gradient of su-
crose and embedded in Optimum Cutting Temperature
(OCT) compound (Tissue-Tek®, Sakura Finetek USA,
Torrance, CA, USA). Five-micron cryo-sections were then
generated and placed on Superfrost Plus slides (Fisher).
Slides were rinsed twice in PBS, quenched with 1% glycine
in PBS and blocked with 2% bovine serum albumin (BSA)
in PBS at room temperature for one hour. Primary anti-
bodies were applied with 1% BSA in PBS overnight at 4°C
and then rinsed twice with PBS containing 0.2% Tween-20.
Secondary antibodies were applied with 1% BSA in PBS at
room temperature for one hour and then slides were rinsed
with PBS containing 0.2% Tween-20 and PBS. Coverslips
were applied to slides after application of Vectashield®
mounting solution with 4′,6-diamidino-2-phenylindole
(DAPI) (1:1 H-1000 to H-1200, Vector Laboratories, Inc.,
Burlingame, CA, USA) used as a nuclear marker. Negative
control samples were incubated identically, except withoutTable 1 Sequence information for primers used in RT-qPCR
Gene symbol Forward primer sequence
Actb 5-AGATGACCCAGATCATGTTTGA
Bgn 5-CTACGCCCTGGTCTTGGTAA
Col1a1 5-TTCTCCTGGCAAAGACGGACTC
Col3a1 5-CACGCAAGGCAATGAGACTA
Col5a1 5-AAGCGTGGGAAACTGCTCTCCT
Col11a1 5-CTGGTCATCCTGGGAAAGAA
Col12a1 5-TGACTACGGTGCAGATGAGC
Col14a1 5-ACCTGTGAGTGTCCCTGGTC
Dcn 5-TGAGCTTCAACAGCATCACC
Emcn 5-CCAACAGTCTCTGCCACAGTG
Scx 5-AAGTTGAGCAAAGACCGTGAC
Tnmd 5-CGCCACACCAGACAAGCA-primary antibody. The primary antibodies that were used
included: 10 μg/ml rabbit anti-mouse collagen I (AB765P,
EMD Millipore, Corp., Billerica, MA, USA), 1:200 rabbit
anti-mouse collagen III (LB-1393, Cosmo Bio USA, Carlsbad,
CA, USA), and 1:100 rabbit anti-mouse collagen V (Myriad
Genetic Laboratories, Inc., Salt Lake City, UT 84108,
USA) [36]. The secondary antibody was an Alexa Fluor
568-conjugated goat anti-rabbit immunoglobulin G (IgG)
(Molecular Probes, Eugene, OR, USA) used at 1:200. Im-
ages were captured using a DM5500 upright microscope
system (Leica) with conditions and integration times set to
facilitate comparisons between samples.
Statistical analyses
These studies utilized both general distribution descrip-
tions as well as tests of statistical significance. Features of
the fibril diameter distributions for each construct group
included mean fibril diameters, standard deviations, me-
dian diameter, and first and third quartile values. Statistical
analyses of fibril diameter distributions were performed
using the unpaired two-tailed t-test comparing mean fibril
diameters of each image analyzed for each group (E15-17,
TP, TP +GDF5, PERI, PERI +GDF5). RT-qPCR results for
progenitor-seeded construct profiles and for expression
profiling results from the conditioned media study were
analyzed using non-parametric Mann–Whitney-Wilcoxon
tests on unpaired samples.
Results
Ultrastructural analysis of progenitor-derived matrix
assembly
This series of experiments tested the hypothesis that the
tendon proper and peritenon progenitors have unique
tenogenic properties when incorporated into the in vitro
regenerative model. The structures of the engineered tis-
sues and the developing tendons were analyzed using
transmission electron microscopy. The progenitor-seededReverse primer sequence
GA-3 5-CACAGCCTGGATGGCTACGT-3
-3 5-ACTTTGCGGATACGGTTGTC-3
AA-3 5-AGGAAGCTGAAGTCATAACCGCCA-3
-3 5-TGGGGTTTCAGAGAGTTTGG-3
AT-3 5-AGCAGTTGTAGGTGACGTTCTGGT-3
-3 5-AGCCCTTGAGACCTCTGACA-3
-3 5-AAGCGACGCAGAGAAAACAT-3
-3 5-AGGCCAGTCAGAGCATCACT-3
-3 5-AAGTCATTTTGCCCAACTGC-3
A-3 5-ACAGAGGCTTTTGTTGTGGAAGTT-3
A-3 5-TGTGGACCCTCCTCCTTCTAAC-3
3 5-CCAGCATTGGGTCAAATTCA-3
Figure 2 Progenitor-derived matrix assembly is ultrastructurally
similar to that of embryonic tendon. Ultrastructure was examined
by cross-sectional images. In both the E15 to E17 Achilles tendon
(A) and the progenitor constructs (B-E), collagen fibril synthesis and
fiber assembly by cell processes are evident with fibers labeled with
black dashed-line ovals (A-E). Panels: Embryonic Achilles tendon
(A), tendon proper (TP)-derived progenitor-seeded construct
(B), peritenon (PERI)-derived progenitor-seeded construct
(C),TP-derived progenitor-seeded construct supplemented with
GDF5 (D), peritenon (PERI)-derived progenitor-seeded construct
supplemented with GDF5 (E). ETC: embryonic tendon cell; TP:
tendon proper-derived progenitor; PP: peritenon-derived progenitor
(Bar: 1 μm). E, embryonic day; GDF5, growth differentiation factor 5.
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similar to that of embryonic tendon. That is, after 45 days
in culture, the ultrastructure analysis of cross-sectional im-
ages from the mid-regions of the constructs shows that
cells seeded within the constructs have processes project-
ing into the matrix compartmentalizing the extracellular
matrix and organizing collections of fibrils into fibers, all
of which is comparable to that observed in embryonic
(E15 to E17) Achilles tendon (Figure 2A-E). Qualitatively,
this is seen for constructs seeded with tendon proper- or
peritenon-derived progenitors when cultured with or with-
out supplementation of GDF5.
An analysis of fibril diameters generated within the con-
structs revealed that overall both progenitor populations
assembled fibrils with embryonic tendon-like features, that
is, unimodal diameter distributions with homogeneous
small diameters. Fibrils assembled by the tendon proper-
derived progenitors demonstrated a broader diameter dis-
tribution shifted to larger diameters than in the embryonic
tendon with larger mean diameters (37.2 ± 6.7 nm versus
32.8 ± 4.7 nm, mean ± sd, P <0.001) (Figure 3A,D,E). The
peritenon-derived progenitor distribution was shifted to
smaller diameters (29.1 ± 6.9 nm, P = 0.002) (Figure 3A,
D,E). However, when GDF5 is supplemented, peritenon-
derived progenitors produce fibrils with a mean diameter
distribution (31.8 ± 4.7 nm) comparable to that of embry-
onic tendon (P = 0.196; Figure 3B,D,E) and no change in
the fibril diameters (37.8 ± 4.7 nm) is noted for tendon
proper-derived progenitors (P = 0.959; Figure 3B,D,E).
Gene expression analyses of progenitors in tendon-like
structures
To test our hypothesis that tendon proper- and peritenon-
derived progenitors have different tenogenic capacities
within the in vitro regenerative model, we analyzed ex-
pression of differentiation markers and matrix assembly
genes early (Day 7) and late (Day 45) in construct for-
mation (Table 2). Expression of tendon differentiation
markers Scx and Tnmd was shown to be different in pre-
seeded tendon proper-derived and peritenon-derived pro-
genitors [4]; in this study, expression of Scx is greater in
Figure 3 (See legend on next page.)
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Figure 3 Mean fibril diameters for constructs were similar to embryonic tendon, and supplemented GDF5 improved peritenon
progenitor-derived construct mean fibril diameters. Fibril diameters of tendon proper progenitor-seeded (TP) constructs were greater than
those of the peritenon-derived progenitor (PERI) constructs as well as those of embryonic Achilles tendon (E15 to E17) (A). Supplementation with
GDF5 increased fibril diameters within PERI constructs (B) but not TP constructs. For each group, the mean fibril diameters with 95% confidence
interval (CI) are compared (C), and fibril diameter analyses are also given for each group (D) – mean fibril diameters ± standard deviation, median,
first and third quartiles. Significant differences are demonstrated via t-test statistical analyses of fibrils analyzed in each group’s images (E).
Replicates (n) represent each image analyzed per group: E15 to E17, n = 32; TP, n = 64; TP + GDF5, n = 32; PERI, n = 32; PERI + GDF5, n = 24. E,
embryonic day; GDF5, growth differentiation factor 5.
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Tnmd (Figure 4A,B; Table 2). Expression of Scx and Tnmd
was significantly greater in tendon proper-derived progen-
itors seeded in constructs (Figure 4A,B; TP versus PERI:
30- to 90-fold and 13- to 21-fold, respectively), while ex-
pression of vascular marker Emcn had a greater expression
level in pre-seeded peritenon-derived progenitors and a
greater trend of expression in peritenon-derived progeni-
tors (Figure 4C; Table 2). Transcript levels for Bgn were
relatively equivalent across cultures (group) and stage
(days) (Figure 4D), but levels for Dcn were significantly
greater in tendon proper-derived progenitors (Figure 4E).
FACIT collagen genes Col12a1 and Col14a1 were sig-
nificantly greater in tendon proper-derived progenitors at
the early time point (Figure 4F,G). Expression of fibrillar
collagen genes Col1a1, Col3a1, Col5a1, and Col11a1 were
generally greater in tendon proper-derived progenitors
seeded in constructs both early and late in culture
(Figure 4H-K).
When the culture was supplemented with recombin-
ant mouse GDF5, expression for matrix assembly genes
in seeded peritenon progenitors increased to levels seen withTable 2 Mean expression fold differences of TP and PERI
constructs
Gene TP PS/PERI PS TP 7/PERI 7 TP 45/PERI 45
Scx 10.55a 94.49b 29.58b
Tnmd 2.07 20.90b 12.90b
Emcn 0.03b 0.80 0.23
Bgn 1.13 3.66 1.54
Dcn 4.92b 6.18b 4.44b
Col1a1 1.76 5.58b 4.75a
Col3a1 2.51a 3.30b 2.63
Col5a1 0.82 2.57 2.26a
Col11a1 2.71 97.40b 5.40a
Col12a1 0.87 3.61b 1.62
Col14a1 2.09 13.42b 0.44
Expression fold differences represent the ratio of means of (Target Gene/Actb)
Group A/(Target Gene/Actb)Group B. PERI: peritenon-derived progenitors; TP:
tendon proper-derived progenitors. Days in culture: pre-seeded (PS), 7 days in
construct (7), 45 days in construct (45). Statistical significance of fold changes
are in bold (aP <0.05; bP <0.01); two-tailed unpaired Mann–Whitney-Wilcoxon
tests were performed. Graphical representations of the data are found
in Figure 4.the seeded tendon proper-derived progenitors (Table 3).
However, after GDF5 supplementation, expression le-
vels for the tendon markers Scx (Figure 5A) and Tnmd
(Figure 5B) were unchanged when comparing GDF5-
supplemented peritenon progenitor expression (PERI+) to
that of tendon proper-derived progenitors not supple-
mented with GDF5 (TP). Expression of vascular marker
Emcn (Figure 5C) also still differed between PERI + and
TP progenitors. GDF5 supplementation did result in im-
proved expression of matrix assembly genes for peritenon
progenitors seeded in tendon constructs comparing
PERI + progenitors and TP progenitors. Bolstered ex-
pression is noted for the small leucine-rich proteogly-
cans (SLRPs) Bgn early (Figure 5D) and Dcn (Figure 5E).
Expression of FACIT collagens Col12a1 (Figure 5F) and
Col14a1 (Figure 5G) as well as fibril-forming collagens
Col1a1 (Figure 5H), Col3a1 (Figure 5I), and Col5a1
(Figure 5J) for GDF5-supplemented PERI + progenitors
also became comparable to TP progenitors, yet expres-
sion of Col11a1 (Figure 5K) was still greater for TP pro-
genitors. Addition of GDF5 did not lead to significant
expression changes among TP progenitors for the ten-
don markers and matrix assembly genes analyzed, ex-
cept for Bgn at 45 days; Additional file 1: Figure S1
exhibits expression results for constructs generated by
cell type, GDF5 supplementation and culture time.
Immuno-histochemial analysis of protein content
To analyze levels of differentiation markers and matrix as-
sembly proteins within the constructs, expression of scler-
axis, collagen I, collagen III, and collagen V in early (Day 7)
constructs was evaluated using immuno-histochemical
analyses. Scleraxis expression was visualized via the Scx
promoter-driven green fluorescent protein (GFP) reporter
present within cells derived from the ScxGFP mouse line
[25]. GFP was detected in all tenocytes of P1 Achilles
tendon yet not in cells of the surrounding peritenon
(Figure 6A-D) Moreover, fewer cells expressed GFP in
TP progenitor-derived constructs (Figure 6E-L); however,
GFP was virtually absent in peritenon progenitor-derived
onstructs (Figure 6M-T), even when supplemented with
GDF5. Expression of collagen I was detectable in Achilles
tendon (Figure 6A) as well as the tendon constructs
(Figure 6E,I,M,Q). Collagen III was detectable in
Figure 4 Expression of tendon differentiation markers and matrix assembly genes is generally greater in tendon proper-derived
progenitors. RT-qPCR analyses demonstrated greater expression of the tendon markers Scx (A) and Tnmd (B) in tendon proper (TP)-derived
progenitors within their respective constructs. However, expression of the vascular marker Emcn (C) was greater in peritenon-derived (PERI)
progenitors. Expression of Bgn (D) remains fairly constant across cell sources, while expression for Dcn (E) is greater in TP-derived progenitor-seeded
tendon constructs. Expression of FACIT collagens Col12a1 (F) and Col14a1 (G) is greater early in culture, particularly for TP-derived progenitors. Gene
expression for fibril-forming collagens Col1a1 (H), Col3a1 (I), and Col5a1 (J) is greater in TP-derived progenitors. Expression of Col11a1 (K) is greatest
early in TP-derived progenitors. (Biological replicates, n = 5 to 8; Mann–Whitney-Wilcoxon test – P <0.01, *; P <0.05, #; fold changes and statistical
significance further reported in Table 2).
Mienaltowski et al. Stem Cell Research & Therapy 2014, 5:86 Page 8 of 15
http://stemcellres.com/content/5/4/86Achilles tendon (Figure 6B) and the tendon constructs
(Figure 6F,J,N,R). Likewise, collagen V was present in
the P1 Achilles tendon (Figure 6C) and the tendon con-
structs (Figure 6G,K,O,S). Thus, expression of fibrillar
collagens is confirmed in the tendon constructs, and dif-
ferential expression of the tendon marker scleraxis among
progenitor-derived constructs is corroborated by Scx
promoter-driven GFP.Gene expression analyses from conditioned media
experiment
During repair, several cell types present in the lesion offer
the opportunity for crosstalk to occur among cells, thus af-
fecting re-establishment of tendon form and function. To
test the hypotheses that different progenitor populations
present in healing tissue are capable of cross talk in the re-
generative response, an in vitro monolayer culture model
Table 3 Mean expression fold differences of PERI
constructs given GDF5 versus TP constructs
Gene TP 7/PERI 7 + GDF5 TP 45/PERI 45 + GDF5
Scx 64.16b 7.75b
Tnmd 13.41b 37.85b
Emcn 0.21a 0.07b
Bgn 1.67 0.59
Dcn 1.69 3.26a
Col1a1 2.81 1.96
Col3a1 1.38 1.30
Col5a1 1.40 1.29
Col11a1 6.46a 6.52a
Col12a1 2.43 2.95
Col14a1 0.84 0.39
Expression Fold Differences represent the ratio of means of (Target Gene/Actb)
Group A/(Target Gene/Actb)Group B. PERI: peritenon-derived progenitors; TP:
tendon proper-derived progenitors. Days in culture: 7 days in construct (7),
45 days in construct (45); +: with GDF5 supplementation. Statistical significance
of fold changes are in bold (aP <0.05; bP <0.01); two-tailed unpaired
Mann–Whitney-Wilcoxon tests were performed. Graphical representations
of the data are found in Figure 5.
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was done to analyze interactions via paracrine stimulatory
products. Gene expression analyses were used to discern
the effects of the cell type-specific secretory products of
peritenon-derived progenitors, tendon proper-derived pro-
genitors, and tenocytes, resulting in nine cell type and
media combinations - cell type (conditioned media): TP
(control), TP (PERI), TP (Tn), PERI (control), PERI (TP),
PERI (Tn), Tn (control), Tn (TP), Tn (PERI). Treatment of
tendon proper-derived progenitors and tenocytes with
peritenon-derived progenitor conditioned media resulted
in increased expression of the tendon markers Scx
(Figure 7A) and Tnmd (Figure 7B), as well as vascular
marker Emcn (Figure 7C). When tendon proper-derived
progenitors and tenocytes were treated with peritenon-
derived progenitor conditioned media (PERI), expression
of matrix assembly genes increased as a trend for Bgn
(Figure 7D), Dcn (Figure 7E) and Col12a1 (Figure 7F).
Significant increases in expression were demonstrated
for Col14a1 (Figure 7G), Col1a1 (Figure 7H), Col3a1
(Figure 7I), Col5a1 (Figure 7J) and Col11a1 (Figure 7K)
in tendon proper-derived progenitors and tenocytes
when treated with peritenon-derived progenitor condi-
tioned media. However, peritenon-derived progenitors
were not stimulated by tendon proper-derived progeni-
tor or tenocyte conditioned media.
Discussion
Intrinsic and extrinsic cells, including stem/progenitors,
have been described as plausible participants in the re-
pair of tendon tears and ruptures [1,2]. In this study, we
demonstrated that stem/progenitor populations of thetendon proper and peritenon of the Achilles tendon are
capable of forming collagen fibril-rich tendon-like struc-
tures in vitro that are comparable to embryonic tendons.
However, we found that there are several differences in
each progenitor population’s ability to regenerate ten-
don. These in vitro differences provide insight into how
these two progenitor populations may behave during
native tendon repair or in tendon formation in tissue
engineering.
While both progenitor populations produced tendon-
like structures when seeded in fibrin gel constructs, as
demonstrated in this study and previously [4], the ten-
don proper-derived progenitors demonstrated greater
levels of tenogenic differentiation by expression of the
tendon markers Scx and Tnmd. Even after supplementa-
tion with the tenogenic modulator GDF5, expression dif-
ferences for these tenogenic marker genes still remained
unchanged, although comparable levels of matrix assem-
bly gene expression were noted. Expression differences of
Scx and Tnmd in these progenitor populations signify the
need for better understanding of the stem/progenitor cells
involved in tendon repair as well as the markers that may
define the origins and, thus, variable differentiation po-
tentials of intrinsic and extrinsic cell populations [37,38].
Since cells from the peritenon enter into lesions early,
these cells are proposed to transdifferentiate into tenocytes
[2]. In the tendon regeneration model, peritenon-derived
progenitors are not differentiating into tenocytes in a man-
ner comparable to progenitors from within the tendon, as
measured by Scx and Tnmd expression and ScxGFP trans-
genic reporter. Thus, from the in vitro results, it could be
stated that not every cell that expresses matrix assembly
genes has transdifferentiated into a tenocyte, but instead
into another collagen-producing cell.
In the regeneration model, ultrastructural similarities
were seen between tendon-like structures developed
from peritenon- and tendon proper-derived progenitors.
That is, progenitors seeded within the constructs had
processes projecting into the matrix that gathered col-
lections of fibrils for further assembly into fibers as in
developing tendons. Also, likewise, these fibrils were
aligned longitudinally, along the tendon axis. However,
diameter distributions varied significantly between struc-
tures produced by tendon proper-derived progenitors
and peritenon-derived progenitors. Differences in fibril
diameters could be the result in differential expression
of regulatory molecules, such as SLRPs and FACIT colla-
gens, as well as fibril nucleating Col5a1 and Col11a1
[34]. The addition of GDF5 did stimulate matrix assem-
bly gene expression in peritenon progenitors, subse-
quently contributing to the corresponding shift in fibril
diameter distributions toward larger diameters. If this is
the case, then this would suggest that GDF5 might also
stimulate matrix assembly gene expression in peritenon
Figure 5 GDF5 supplementation causes improved expression matrix assembly genes in peritenon progenitors seeded in constructs.
After r-mGDF5 supplementation, expression levels for the tendon markers Scx (A) and Tnmd (B) and the vascular marker Emcn (C) still differed.
GDF supplementation led to improved expression of matrix assembly genes for peritenon progenitors seeded in tendon constructs - comparing
PERI + versus TP at Day 7 (early) and Day 45 (late). Bolstered expression is noted for SLRPs Bgn (D) and early for Dcn (E), for FACIT collagens
Col12a1 (F) and Col14a1 (G), and for fibril-forming collagens Col1a1 (H), Col3a1 (I) and Col5a1 (J). Expression of Col11a1 (K) is still greater for
tendon proper-derived progenitors. (Biological replicates, n = 5 to 8; Mann–Whitney-Wilcoxon test – P <0.01, *; P <0.05, #; fold changes and
statistical significance further reported in Table 3 and expanded results are reported in Additional file 1: Figure S1). GDF5, growth differentiation
factor 5; PERI, peritenon-derived progenitors; SLRP, small leucine-rich proteoglycans; TP, tendon proper-derived progenitors.
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tor, such as Mohawk, or the early growth response tran-
scription factors Egr1 and Egr2 [14,27,39]. Certainly,
transcription factors besides Scx are active in stimulating
transcription of type I procollagen genes and other matrix
assembly genes, even in the tendon [40,41]. Further stud-
ies are required to determine each transcription factor’s
involvement in activation of intrinsic and extrinsic cells in
repair.In examining gene expression of tendon markers and
matrix assembly early and late in fibrin gel-based con-
struct cultures, gene expression waned to various extents
from Day 7 to Day 45, particularly for TP constructs.
However, the decrease in expression was not statistically
significant, except for Col11a1 and Col14a1, although
decreases occur in expression for these two genes in de-
veloping tendons [34,42,43]. In fact, expression for many
matrix assembly genes wanes over time as tendon
Figure 6 Fibrillar collagens were present in the tendon constructs. Staining for collagens I, III and V was analyzed in P1 Achilles tendon and
progenitor-derived tendon constructs at Day 7. Because the tissue and cells originate from ScxGFP transgenic mice, cells with an active Scx
promoter contain green fluorescent protein (GFP). In the P1 Achilles tendon, GFP allows for delineation (white dashed line) of peritenon (peri)
and tendon proper (tp) (A-D). Active GFP was also detected for TP-derived progenitors in constructs (white arrows, E-L). As with the P1 Achilles
tendon, TP, TP + GDF5, PERI, and PERI + GDF5 constructs were positive for staining for collagen I (A, E, I, M, Q), collagen III (B, F, J, N, R) and
collagen V (C, G, K, O, S). Negative controls represent staining with secondary antibody only (D, H, L, P, T) (Bar: 100 μm).
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Figure 7 Peritenon-derived progenitor conditioned media stimulates expression of tendon differentiation markers and matrix
assembly genes. Treatment of tendon proper-derived progenitors and tenocytes with peritenon-derived progenitor conditioned media (PERI)
resulted in increased expression of the tendon markers Scx (A) and Tnmd (B), as well as vascular marker Emcn (C). When tendon proper-derived
progenitors and tenocytes were treated with PERI conditioned media, expression of matrix assembly genes increased as a trend for Bgn (D), Dcn
(E), Col12a1 (F) and Col11a1 (K); and significantly for Col14a1 (G), Col1a1 (H), Col3a1 (I) and Col5a1 (J). Peritenon-derived progenitors were not
stimulated by tendon proper-derived progenitor or tenocyte conditioned media. (Biological replicates, n = 4 to 8; Mann–Whitney-Wilcoxon test
relative to control media for each cell type for each gene assayed – P <0.01, *; P <0.05, #).
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occurs [6,9,34,42,44,45]. Whether or not this decrease in
expression represents the construct reaching a homeostatic
state is still something to be determined. This suggests thatother stimuli might be necessary to further stimulate the
constructs as they form tendon-like structures.
In the debate over the roles of intrinsic and extrinsic
cell sources in repair, it is believed that extrinsic cells
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demonstrated that peritenon-derived progenitors secrete
a factor or factors that bolster expression of tenogenic
differentiation markers and matrix assembly genes in
tendon proper-derived progenitors and mature teno-
cytes, thus suggesting another role for peritenon-derived
progenitors besides synthesis of provisional matrix dur-
ing tendon repair. This stimulatory effect also highlights
the necessity for considering the interactions of all in-
trinsic and extrinsic cells involved in tendon repair, be-
sides tendon niche components, breakdown products, as
well as inflammatory mediators. In a recent study, the
stimulatory effect of tendon cells has also been demon-
strated to promote tenogenic differentiation in amniotic
epithelial cells in co-culture [47]. Thus, cell-cell signaling
could be invaluable for cuing tenogenic differentiation in
native repair; likewise, manipulation of this signaling
could lead to improvements in regenerative tissue engin-
eering strategies.
This study did have a few limitations. Only one concen-
tration of GDF5 was used in these studies. This concentra-
tion was selected because it had been effective for other
mesenchymal stromal cell-based studies [23,27,48,49].
Furthermore, while this study focused on GDF5, several
other growth differentiation factors have been implicated
in tendon development and could also merit further in-
vestigation within the model [50-54]. Moreover, further
analyses of morphological structure, particularly dynamic
tracking techniques, would be useful for understanding
cell behavior within the developing constructs as cells
undergo tenogenic differentiation and initiate tendon for-
mation [55-57].
It should be noted that prior to the conditioned media
study, cells were expanded in media for a two week period
and then cells were trypsinized and then re-seeded, which
is essentially the first passage. Progenitors were expanded
in progenitor selective media [3,4]. Tenocytes were ex-
panded in media with 10% FBS; supplementation of media
with 10% FBS has been demonstrated to be acceptable
for tenocyte expansion [11,58], although phenotypic drift
could become a concern after long periods of time or mul-
tiple passages [28]. Phenotypic drift related to long-term,
multiple passage culture is also a concern for progenitor
cells [59].
Lastly, the progenitors in this study were examined via
in vitro models. The tendon-forming capabilities of pro-
genitors were analyzed in the fibrin gel model, and
enriched progenitor populations – tendon proper versus
peritenon – were examined individually, although in na-
tive repair intrinsic and extrinsic sources may interact to
influence repair, as was demonstrated by the conditioned
media study. The purpose of the conditioned media study
was to offer evidence of cell-cell interactions via paracrine
effects to highlight the importance of considering morethan one cell type within the healing niche. Future studies
are planned to discern how this synergistic interaction can
be influenced to regenerate tendon-specific structure and
function in engineered constructs via co-culture as well as
in situ during repair via cell tracking within healing ten-
don tissue.Conclusions
We demonstrated that progenitors from the tendon
proper and the peritenon are capable of forming collagen-
rich structures. While TPs are more suited for regener-
ation of tendon structure, the addition of GDF5 stimulated
matrix assembly for PERIs. Moreover, PERIs secreted
tendon-promoting factors that bolster expression of ten-
don markers in TPs and tenocytes. These findings suggest
that progenitors in and around the Achilles tendon pos-
sess unique tenogenic differentiation characteristics. Dis-
tinctions found in tenogenic differentiation and matrix
assembly potentials between these progenitor pools pro-
vide insight into possible individual and interactive roles
of multiple intrinsic and extrinsic cell populations during
tendon repair.Additional file
Additional file 1: Figure S1. GDF5 supplementation causes improved
expression matrix assembly genes in peritenon progenitors seeded in
constructs: an expanded view. After r-mGDF5 supplementation, expression
levels for tendon markers Scx (A) and Tnmd (B) and vascular marker
Emcn (C) still differed. GDF5 supplementation led to improved
expression of matrix assembly genes for peritenon progenitors seeded in
tendon constructs -comparing PERI + vs. TP: Day 7 (early), red boxes; Day 45
(late), blue boxes. Bolstered expression is noted for SLRPs Bgn (D) and early for
Dcn (E), for FACIT collagens Col12a1 (F) and Col14a1 (G), and for fibril-forming
collagens Col1a1 (H), Col3a1 (I), and Col5a1 (J). Expression of Col11a1 (K) is still
greater for tendon proper-derived progenitors. Biological replicates are given
below each panel for each group. Statistical significance is specifically queried
for PERI 7+ vs. TP 7 and PERI 45+ vs. TP 45 (Biological replicates, n = 5 to 8;
Mann–Whitney-Wilcoxon test – P <0.01, *; P <0.05, #).Abbreviations
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